Cargando…
The chemokine CCL17 is a novel therapeutic target for cardiovascular aging
Autores principales: | Zhang, Yang, Tang, Xiaoqiang, Wang, Zeyuan, Wang, Lun, Chen, Zhangwei, Qian, Ju-Ying, Tian, Zhuang, Zhang, Shu-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113193/ https://www.ncbi.nlm.nih.gov/pubmed/37072419 http://dx.doi.org/10.1038/s41392-023-01363-1 |
Ejemplares similares
-
CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure
por: Zhang, Yang, et al.
Publicado: (2022) -
CC chemokines CCL2, CCL3, CCL4 and CCL5 are elevated in osteoporosis patients
por: Farangis, Fatehi, et al.
Publicado: (2017) -
Macrophage derived chemokine (CCL22), thymus and activation-regulated chemokine (CCL17), and CCR4 in idiopathic pulmonary fibrosis
por: Yogo, Yurika, et al.
Publicado: (2009) -
The C-C Chemokines CCL17 and CCL22 and Their Receptor CCR4 in CNS Autoimmunity
por: Scheu, Stefanie, et al.
Publicado: (2017) -
CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction
por: Hueso, Luisa, et al.
Publicado: (2023)